07.01.11
Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company based in San Diego, CA, has been acquired by Switzerland-based Nestlé Health Science S.A., a wholly-owned subsidiary of Nestlé S.A. With the goal of pioneering science-based nutritional solutions in order to deliver improved personalized healthcare for medical conditions, Nestlé Health Science became operational in January 2011. In the long term, the company aims to use nutritional solutions to change the healthcare paradigm and deliver affordable and effective health benefits, which are also safe and sustainable. Prometheus’ capabilities strongly support Nestlé Health Science’s ambitions.
“This is a strategic move into gastrointestinal diagnostics,” said Luis Cantarell, Nestlé Health Science president and CEO. “Prometheus’s leading edge diagnostics technology and outstanding sales force will help us to develop an integrated approach to personalized healthcare. It is fully consistent with our vision of pioneering science-based nutritional solutions to deliver improved personalized healthcare for medical conditions.” (For more in-depth analysis on this acquisition, go here.)
“This is a strategic move into gastrointestinal diagnostics,” said Luis Cantarell, Nestlé Health Science president and CEO. “Prometheus’s leading edge diagnostics technology and outstanding sales force will help us to develop an integrated approach to personalized healthcare. It is fully consistent with our vision of pioneering science-based nutritional solutions to deliver improved personalized healthcare for medical conditions.” (For more in-depth analysis on this acquisition, go here.)